共 50 条
- [41] Prostate cancer and prostate-specific antigen (PSA) screening in AustriaProstatakarzinom und PSA-Screening in Österreich Wiener klinische Wochenschrift, 2005, 117 : 457 - 461
- [42] IMPACT OF EXPOSURE RATE OF PROSTATE SPECIFIC ANTIGEN (PSA) SCREENING ON INCIDENCE OF METASTATIC PROSTATE CANCER IN JAPAN JOURNAL OF UROLOGY, 2009, 181 (04): : 798 - 799
- [43] Body mass index and impact on PSA screening and prostate cancer detection in the PLCO trial JOURNAL OF UROLOGY, 2006, 175 (04): : 155 - 155
- [44] Impact of exposure rate of PSA-screening on clinical stage of prostate cancer in Japan JOURNAL OF UROLOGY, 2006, 175 (04): : 477 - 478
- [45] Adding age and genetic risk to PSA test could improve screening for prostate cancer BRITISH MEDICAL JOURNAL, 2012, 345
- [46] USE OF A 1.5 PSA THRESHOLD TO IDENTIFY INCREASED RISK FOR PROSTATE CANCER IN A SCREENING POPULATION JOURNAL OF UROLOGY, 2010, 183 (04): : E665 - E666
- [47] Re: Lifetime Benefits and Harms of PSA-Based Risk Screening for Prostate Cancer JOURNAL OF UROLOGY, 2020, 204 (01): : 186 - 187
- [48] PSA screening significantly cuts risk of death from prostate cancer, review finds BMJ-BRITISH MEDICAL JOURNAL, 2017, 358